Trial Details

UNKNOWN
Basic Information
Clinical ID c1007
Identifier NCT05705856
Trial Title Effectiveness and Safety of Ustekinumab Intensification in Crohn's Disease
Trial URL Visit Original Page
Study Information
Study Results

NO

Conditions Crohn Disease
Interventions DRUG: Ustekinumab
Participant Information
Sponsor Second Affiliated Hospital, School of Medicine, Zhejiang University
City Zhejiang
Country/Region China
Enrollment Criteria
Sex Requirement ALL
Age Requirement ADULT, OLDER_ADULT
Study Design
Study Type OBSERVATIONAL
Phase NULL
Time Information
Start Date 2023-02-15
Primary Completion Date 2023-12-31
Completion Date 2024-06-01